Liquid Biopsy 117 Gene Panel: Comprehensive Cancer Genetic Testing
Introduction to Liquid Biopsy Technology
The Liquid Biopsy 117 Gene Panel represents a groundbreaking advancement in cancer diagnostics and genetic testing. Unlike traditional tissue biopsies that require invasive procedures, this innovative test analyzes circulating tumor DNA (ctDNA) and other biomarkers present in the bloodstream. This non-invasive approach provides comprehensive genetic information about cancer-related mutations without the discomfort and risks associated with surgical biopsies.
Liquid biopsy technology has revolutionized cancer care by enabling early detection, treatment monitoring, and personalized medicine approaches. The 117-gene panel covers a wide spectrum of cancer-related genes, making it one of the most comprehensive liquid biopsy tests available today. This test is particularly valuable for patients who cannot undergo traditional biopsies or require ongoing monitoring of their cancer status.
What the Test Measures and Detects
The Liquid Biopsy 117 Gene Panel utilizes Next-Generation Sequencing (NGS) technology to analyze 117 key cancer-related genes from a simple blood sample. The test detects:
- Genetic mutations in oncogenes and tumor suppressor genes
- Single nucleotide variants (SNVs) and insertions/deletions (indels)
- Copy number variations (CNVs) associated with cancer development
- Circulating tumor DNA (ctDNA) biomarkers
- Genetic variants linked to inherited cancer susceptibility
- Biomarkers for targeted therapy response prediction
This comprehensive analysis provides crucial information about cancer driver mutations, treatment resistance markers, and potential therapeutic targets. The test can identify mutations in genes such as BRCA1, BRCA2, TP53, EGFR, KRAS, and many others that play critical roles in cancer development and progression.
Who Should Consider This Test
The Liquid Biopsy 117 Gene Panel is recommended for individuals in the following situations:
Cancer Patients and Survivors
- Patients with diagnosed cancer seeking comprehensive genetic profiling
- Individuals requiring treatment selection and monitoring
- Cancer survivors for ongoing surveillance and recurrence monitoring
- Patients with metastatic cancer for therapy response assessment
High-Risk Individuals
- People with strong family history of cancer
- Individuals with known genetic cancer syndromes
- Those with previous abnormal cancer screening results
- People with lifestyle factors increasing cancer risk
Proactive Health Screening
- Individuals interested in comprehensive cancer risk assessment
- People seeking early detection opportunities
- Those wanting personalized cancer prevention strategies
Benefits of Taking the Liquid Biopsy 117 Gene Panel
Choosing this advanced genetic test offers numerous advantages for patients and healthcare providers:
- Non-Invasive Procedure: Simple blood draw eliminates the need for surgical biopsies
- Comprehensive Analysis: 117 gene coverage provides extensive genetic information
- Early Detection Potential: Can identify cancer biomarkers before symptoms appear
- Treatment Guidance: Helps oncologists select targeted therapies
- Monitoring Capability: Enables tracking of treatment response and disease progression
- Personalized Medicine: Supports development of individualized treatment plans
- Convenient Testing: Minimal disruption to daily life with quick sample collection
- Reduced Risk: Avoids complications associated with invasive procedures
Understanding Your Test Results
Your Liquid Biopsy 117 Gene Panel results will provide detailed information about your genetic profile related to cancer risk and biomarkers. Here’s how to interpret the general findings:
Positive Results
If the test detects specific genetic mutations or cancer biomarkers, this indicates:
- Presence of circulating tumor DNA suggesting active cancer
- Genetic mutations that may increase cancer risk
- Biomarkers that could guide targeted therapy selection
- Opportunities for early intervention and preventive measures
Negative Results
A negative result typically means:
- No detectable cancer-related genetic mutations in the analyzed genes
- Low levels of circulating tumor DNA below detection threshold
- Reduced likelihood of having the specific cancers covered by the panel
Variant of Uncertain Significance (VUS)
Some results may show genetic variants whose clinical significance is not yet fully understood. These require:
- Consultation with a genetic counselor or oncologist
- Possible additional testing or family member testing
- Ongoing monitoring as research evolves
Important: All results should be discussed with your healthcare provider who can provide personalized interpretation based on your complete medical history and clinical context.
Test Pricing and Details
| Test Component | Price (USD) |
|---|---|
| Discount Price | $826 |
| Regular Price | $1,000 |
| Test Name | Liquid Biopsy 117 Gene Panel |
| Turnaround Time | 25 Working Days |
| Sample Type | Streck Tube Black Top |
Pre-Test Instructions and Requirements
Before scheduling your Liquid Biopsy 117 Gene Panel, please note the following important requirements:
- Doctor’s Prescription Required: This test must be ordered by a licensed healthcare provider
- Prescription Exceptions: Prescription is not required for surgery preparation, pregnancy cases, or international travel purposes
- Sample Collection: Blood sample collected in Streck Tube (Black Top)
- Preparation: No special preparation required; can be done at any time
- Consultation: Genetic counseling recommended for comprehensive result interpretation
Nationwide Availability
We have testing facilities and collection centers across the United States, serving patients in all major metropolitan areas including:
- New York City and surrounding areas
- Los Angeles and Southern California
- Chicago and Midwest regions
- Houston and Texas metropolitan areas
- Phoenix and Arizona locations
- Philadelphia and Northeast regions
- And many more locations nationwide
Our network of certified collection centers ensures convenient access to this advanced genetic testing regardless of your location in the United States.
Take Control of Your Health Today
The Liquid Biopsy 117 Gene Panel offers unprecedented insight into your cancer genetic profile through cutting-edge technology. With our discounted price of $826 USD (regularly $1,000), this comprehensive testing is more accessible than ever.
Ready to schedule your test? Contact us today to book your appointment or speak with our genetic specialists:
Call or WhatsApp: +1(267) 388-9828
Our team is available to answer your questions, help with scheduling, and provide guidance throughout the testing process. Take the first step toward personalized cancer risk assessment and proactive health management with the advanced Liquid Biopsy 117 Gene Panel.
